Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study

Journal of Clinical Oncology

Volumn 30, Issue 7, 2012, Pages 695-700

  Walker, Joan L ^a   Piedmonte, Marion R ^b   Spirtos, Nick M ^e   Eisenkop, Scott M ^e   Schlaerth, John B ^f   Mannel, Robert S ^a   Barakat, Richard ^c   Pearl, Michael L ^d   Sharma, Sudarshan K ^g  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^e Women's Cancer Center of Nevada   (United States)

^f Pacific Gynecologic Specialists   (United States)

^g Adventist Hinsdale Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; LAPAROSCOPY; LAPAROTOMY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SALPINGOOOPHORECTOMY; UTERUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; LAPAROTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIECTOMY; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84863393302     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.8645     Document Type: Article

References (21)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60:277-300, 2010
2. Mutch DG: The New FIGO staging system for cancers of the vulva, cervix, endometrium, and sarcomas. Gynecol Oncol 115:325-328, 2009
3. Creasman WT, Morrow CP, Bundy BN, et al: Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035-2041, 1987
4. Morrow CP, Bundy BN, Kurman FJ, et al: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group Study. Gynecol Oncol 40:55-65, 1991
5. Bristow RE, Zerbe MJ, Rosenshein NB, et al: Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78:85-91, 2000 (Pubitemid 30650336)
6. Randall ME, Filiaci VL, Muss H, et al: Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 24:36-44, 2006 (Pubitemid 46630491)
7. Homesley HD, Filiaci V, Gibbons SK, et al: A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group Study. Gynecol Oncol 112:543-552, 2009
8. Keys HM, Roberts JA, Brunetto VL, et al: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 92:744-751, 2004 (Pubitemid 38251372)
9. Aalders J, Abeler V, Kolstad P, et al: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419-427, 1980 (Pubitemid 10018299)
10. Nout RA, Smit VT, Putter H, et al: Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label non-inferiority, randomized trial. Lancet 375:816-823, 2010
11. Walker JL, Piedmonte MR, Spirtos NM, et al: Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 27:5331-5336, 2009
12. Kornblith AB, Huang HQ, Walker JL, et al: Quality of life of patients with endometrial cancer undergoing laparoscopic surgical staging compared to laparotomy. J Clin Oncol 27:5337-5342, 2009
13. Lan KKG, DeMets DL: Discrete sequential boundaries for clinical trials. Biometrika 70:659-663, 1984
14. Cox DR: Regression models and life-tables. J Royal Stat Soc B 34:187-220, 1972
15. Korn EL, Dorey FJ: Applications of crude incidence curves. Stat Med 11:813-829, 1992
16. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 1980, pp 163-178
17. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al: The analysis of failure times in the presence of competing risks. Biometrics 34:541-554, 1978 (Pubitemid 9067879)
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-486, 1958
19. Kitchener H, Swart AM, Qian Q, et al: Efficacy of systematic pelvic lymphadenectomy I endometrial cancer (MRC ASTEC trial): A randomized study. Lancet 373:125-136, 2009
20. Benedetti Panici P, Basile S, Maneschi F, et al: Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst 100:1707-1716, 2008
21. Janda M, Gebski V, Brand A, et al: Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): A randomised trial. Lancet Oncol 11:772-780, 2010